Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/14/2026

Triamcinolone Acetonide Therapy

Intralesional Injections

  • Triamcinolone acetonide (5-10 mg/mL) can be injected for treating patchy alopecia areata, with injections being most suitable for limited patches of hair loss and cosmetically sensitive areas like eyebrows 1, 2
  • A small injection of 0.05-0.1 mL can produce a tuft of hair growth approximately 0.5 cm in diameter 2

Acne Treatment

  • Intralesional injection of triamcinolone acetonide is commonly used for managing larger, nodular acne lesions, providing rapid improvement and decreased pain in inflammatory acne nodules 3

Administration Considerations

  • The American Academy of Dermatology recommends using the minimum effective amount to control symptoms 4
  • Apply sparingly to skin folds and intertriginous areas to minimize the risk of atrophy 4

Potential Adverse Effects

  • Skin atrophy at injection sites is a consistent side effect of intralesional corticosteroid therapy, particularly with triamcinolone 2
  • Folliculitis is a common side effect when using potent topical steroids 1

Best Practices for Use

  • The American Academy of Dermatology recommends gradual reduction in application frequency after clinical improvement 4
  • Consider twice-weekly application for maintenance therapy to maintain disease control while minimizing adverse effects 4

Risk of Intralesional Steroid Use in Periocular Areas

Safety Considerations

  • Intralesional triamcinolone should never be administered in peri‑ocular regions because of rare but potentially catastrophic central retinal artery embolization that can cause permanent vision loss【5】.

REFERENCES

2

guidelines for the management of alopecia areata. [LINK]

British Journal of Dermatology, 2003

3

guidelines of care for the management of acne vulgaris. [LINK]

Journal of the American Academy of Dermatology, 2016

4

Management of Corticosteroid-Responsive Dermatoses [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025